1 of 4
FEATURED COMPANIES
- Abott Laboratories
- C.R Bard Inc.
- Cryolife Inc.
- LivaNova PLC
- St. Jude Medical, Inc
- MORE
The structural heart device manufacture landscape is diverse and continually evolving. Major players in structural heart device market have diversified product portfolios, strong geographical reach, and have made several strategic initiatives. The dynamics of the structural heart device market extends beyond routine macro-economic elements of supply and demand. It is the relationship between buyer's needs and seller's capabilities as well as the macroeconomic forces at work that affect the market. It is how well and how efficiently the sellers meet the needs of the buyers that determine long-term success.
Over the years, the level of demand for structural heart device has increased due to growing adoption of minimally invasive procedures for heart valve repair and replacement. Structural heart devices are used for a variety of replacement process, such as surgical valves, mechanical heart valves, tissue heart valves, and transcatheter aortic valves and is forecast to grow at a CAGR of 14%. The major growth drivers for this market are the growing demand for minimally invasive surgery, growing healthcare expenditure, and a growing geriatric population.
Firms that produce structural heart device are approaching market opportunities with starkly different strategies. The analyst, a leading global management consulting and market research firm, has analyzed the global structural heart device suppliers and has come up with a comprehensive research report, “Leadership Quadrant and Strategic Positioning of Structural Heart Device Suppliers”. Using its proprietary research methodology, the analyst has developed a comparative analysis tool, the ‘Leadership Quadrant,’ which identifies leaders, contenders, visionaries, and specialists in the structural heart device market and rates each structural heart device producer.
This report also offers a full competitive analysis from target markets to product mapping, from selling strategies to production capabilities. In this research study, eight companies such as Edwards Lifesciences Corporation, Medtronic Public Limited Company, St. Jude Medical, Inc, Boston Scientific Corporation, LivaNova PLC, Abott Laboratories, C.R Bard Inc., and Cryolife Inc. were analyzed and profiled because they are the top revenue producers for structural heart device. The eight profiled manufacturers are grouped in the quadrant. The leadership quadrant analyzes the relative strength among these players. The leadership quadrant addresses the need in the market for manufacturer evaluation based on objective data and metrics.
A total of 60 figures/charts and 6 tables are provided in this 140-pages report to help in your business decisions.
Collected from a series of primary vendor interviews and secondary sources, the analyst provides its own scorecard for determining which of these companies is better aligned with future market opportunities and which has the ability to gain additional market share. Using its proprietary research methodology, the analyst has developed a comparative analysis tool, the ‘Leadership Quadrant,’ which identifies leaders and challengers in the structural heart device market and rates each structural heart device producer on two primary criteria as shown below:
Some of the features of this research study are as follows:
Leadership and competitive analysis:
This unique report will provide you with valuable information, insights, and tools needed to identify new growth opportunities and operate your business successfully in this market. This report will save hundreds of hours of your own personal research time and will significantly benefit you in expanding your business in this market.
This report answers the following key questions:
Over the years, the level of demand for structural heart device has increased due to growing adoption of minimally invasive procedures for heart valve repair and replacement. Structural heart devices are used for a variety of replacement process, such as surgical valves, mechanical heart valves, tissue heart valves, and transcatheter aortic valves and is forecast to grow at a CAGR of 14%. The major growth drivers for this market are the growing demand for minimally invasive surgery, growing healthcare expenditure, and a growing geriatric population.
Firms that produce structural heart device are approaching market opportunities with starkly different strategies. The analyst, a leading global management consulting and market research firm, has analyzed the global structural heart device suppliers and has come up with a comprehensive research report, “Leadership Quadrant and Strategic Positioning of Structural Heart Device Suppliers”. Using its proprietary research methodology, the analyst has developed a comparative analysis tool, the ‘Leadership Quadrant,’ which identifies leaders, contenders, visionaries, and specialists in the structural heart device market and rates each structural heart device producer.
This report also offers a full competitive analysis from target markets to product mapping, from selling strategies to production capabilities. In this research study, eight companies such as Edwards Lifesciences Corporation, Medtronic Public Limited Company, St. Jude Medical, Inc, Boston Scientific Corporation, LivaNova PLC, Abott Laboratories, C.R Bard Inc., and Cryolife Inc. were analyzed and profiled because they are the top revenue producers for structural heart device. The eight profiled manufacturers are grouped in the quadrant. The leadership quadrant analyzes the relative strength among these players. The leadership quadrant addresses the need in the market for manufacturer evaluation based on objective data and metrics.
A total of 60 figures/charts and 6 tables are provided in this 140-pages report to help in your business decisions.
Collected from a series of primary vendor interviews and secondary sources, the analyst provides its own scorecard for determining which of these companies is better aligned with future market opportunities and which has the ability to gain additional market share. Using its proprietary research methodology, the analyst has developed a comparative analysis tool, the ‘Leadership Quadrant,’ which identifies leaders and challengers in the structural heart device market and rates each structural heart device producer on two primary criteria as shown below:
- Alignment with market opportunity
- Ability to gain market share
Some of the features of this research study are as follows:
Leadership and competitive analysis:
- Product mapping of leading players
- Benchmarking of financial strength of leading players
- Leadership quadrant/strategic positioning of players
- Leaders
- Contenders
- Visionaries
- Specialists
- North America
- Europe
- Asia Pacific
- The Rest of the World
- Product positioning
- Market positioning
- Financial strength
- Revenue breakdown by market segments
- Revenue breakdown by regions
- Organizational capabilities
- Innovation and market leadership
This unique report will provide you with valuable information, insights, and tools needed to identify new growth opportunities and operate your business successfully in this market. This report will save hundreds of hours of your own personal research time and will significantly benefit you in expanding your business in this market.
This report answers the following key questions:
- What are the market shares of suppliers in various replacement process segments such as in surgical valves, mechanical heart valves, tissue heart valves, and transcatheter aortic valves?
- Who are the market leaders in various regions and what are their market shares?
- Which companies are more aligned with market opportunities and which companies have ability to gain market share?
- What are the key differentiators for major suppliers?
- Which company has the widest product range and how the product mapping looks among various players?
- Which companies will gain market share?
Note: Product cover images may vary from those shown
2 of 4
FEATURED COMPANIES
- Abott Laboratories
- C.R Bard Inc.
- Cryolife Inc.
- LivaNova PLC
- St. Jude Medical, Inc
- MORE
1. Leadership Analysis
1.1: Market Description
1.2: Scoring Criteria
1.3: Leadership Quadrant Analysis
1.3.1: Leaders (Top Right)
1.3.2: Contenders (Bottom Right)
1.3.3: Visionaries (Top Left)
1.3.4: Specialists (Lower Left)
2. Competitive Benchmarking
2.1: Product Portfolio Analysis
2.2: Financial Strength
2.3: Market Share Analysis
2.3.1: Market Share in Various Segments
2.3.2: Market Share in Various Regions
3. Edwards Lifesciences Corporation Profile
3.1: Company Overview
3.1.1: Edwards Lifesciences Corporation Company Description and Business Segments
3.1.2: Edwards Lifesciences Corporation Company Statistics
3.2: Structural Heart Device Business Overview
3.2.1: Structural Heart Device Business Segment
3.2.2: Global Structural Heart Device Operations
3.2.3: Key Differentiators and Strengths
3.3: Products and Product Positioning
3.3.1: Product Line Overview
3.3.2: Structural Heart Device Product Mapping
3.3.3: Product Positioning in Market Segments
3.4: Markets and Market Positioning
3.4.1: Market Position in Global Structural Heart Device Business
3.5: Revenue Breakdown by Market Segments
3.6: Revenue Breakdown by Regions
3.7: Production
3.7.1: Global Manufacturing Operations
3.8: Innovation and Market Leadership
3.9: Marketing, Sales, and Organizational Capabilities
3.9.1: Marketing and Sales
3.9.2: Management Commitment and Track Record
3.10: Financial Strength
4. Medtronic Public Limited Company Profile
4.1: Company Overview
4.1.1: Medtronic Public Limited Company Description and Business Segments
4.1.2: Medtronic Public Limited Company Statistics
4.2: Structural Heart Device Business Overview
4.2.1: Structural Heart Device Business Segment
4.2.2: Global Operations in Structural Heart Device
4.2.3: Key Differentiators and Strengths
4.3: Products and Product Positioning
4.3.1: Product Line Overview
4.3.2: Structural Heart Device Product Mapping
4.3.3: Product Positioning in Market Segments
4.4: Markets and Market Positioning
4.4.1: Market Position in Global Structural Heart Device Business
4.5: Revenue Breakdown by Market Segments
4.6: Revenue Breakdown by Regions
4.7: Production
4.7.1: Global Manufacturing Operations
4.8: Innovation and Market Leadership
4.9: Marketing, Sales, and Organizational Capabilities
4.9.1: Marketing and Sales
4.9.2: Management Commitment and Track Record
4.10: Financial Strength
5. St. Jude Medical, Inc. Profile
5.1: Company Overview
5.1.1: St. Jude Medical, Inc. Company Description and Business Segments
5.1.2: St. Jude Medical, Inc. Company Statistics
5.2: Structural Heart Device Business Overview
5.2.1: Structural Heart Device Business Segment
5.2.2: Global Structural Heart Device Operations
5.2.3: Key Differentiators and Strengths
5.3: Products and Product Positioning
5.3.1: Product Line Overview
5.3.2: Product Mapping
5.3.3: Product Positioning in Market Segments
5.4: Markets and Market Positioning
5.4.1: Market Position in Global Structural Heart Device Business
5.5: Revenue Breakdown by Market Segments
5.6: Revenue Breakdown by Regions
5.7: Production
5.7.1: Global Manufacturing Operations
5.8: Innovation and Market Leadership
5.9: Marketing, Sales, and Organizational Capabilities
5.9.1: Marketing and Sales
5.9.2: Management Commitment and Track Record
5.10: Financial Strength
6. Boston Scientific Corporation Profile
6.1: Company Overview
6.1.1: Boston Scientific Corporation Company Description and Business Segments
6.1.2: Boston Scientific Corporation Company Statistics
6.2: Structural Heart Device Business Overview
6.2.1: Structural Heart Device Business Segment
6.2.2: Global Structural Heart Device Operations
6.2.3: Key Differentiators and Strengths
6.3: Products and Product Positioning
6.3.1: Product Line Overview
6.3.2: Structural Heart Device Product Mapping
6.3.3: Product Positioning in Market Segments
6.4: Markets and Market Positioning
6.4.1: Market Position in Global Structural Heart Device Business
6.5: Revenue Breakdown by Market Segments
6.6: Revenue Breakdown by Regions
6.7: Production
6.7.1: Global Manufacturing Operations
6.8: Innovation and Market Leadership
6.9: Marketing, Sales, and Organizational Capabilities
6.9.1: Marketing and Sales
6.9.2: Management Commitment and Track Record
6.10: Financial Strength
7. LivaNova PLC Profile
7.1: Company Overview
7.1.1: LivaNova PLC Company Description and Business Segments
7.1.2: LivaNova PLC Company Statistics
7.2: Structural Heart Device Business Overview
7.2.1: Structural Heart Device Business Segment
7.2.2: Global Structural Heart Device Operations
7.2.3: Key Differentiators and Strengths
7.3: Products and Product Positioning
7.3.1: Product Line Overview
7.3.2: Structural Heart Device Product Mapping
7.3.3: Product Positioning in Market Segments
7.4: Markets and Market Positioning
7.4.1: Market Position in Global Structural Heart Device Business
7.5: Revenue Breakdown by Market Segments
7.6: Revenue Breakdown by Regions
7.7: Production
7.7.1: Global Manufacturing Operations
7.8: Innovation and Market Leadership
7.9: Marketing, Sales, and Organizational Capabilities
7.9.1: Marketing and Sales
7.9.2: Management Commitment and Track Record
7.10: Financial Strength
8. Abott Laboratories Profile
8.1: Company Overview
8.1.1: Abott Laboratories Company Description and Business Segments
8.1.2: Abott Laboratories Company Statistics
8.2: Structural Heart Device Business Overview
8.2.1: Structural Heart Device Business Segment
8.2.2: Global Structural Heart Device Operations
8.2.3: Key Differentiators and Strengths
8.3: Products and Product Positioning
8.3.1: Product Line Overview
8.3.2: Structural Heart Device Product Mapping
8.3.3: Product Positioning in Market Segments
8.4: Markets and Market Positioning
8.4.1: Market Position in Global Structural Heart Device Business
8.5: Revenue Breakdown by Market Segments
8.6: Revenue Breakdown by Regions
8.7: Production
8.7.1: Global Manufacturing Operations
8.8: Innovation and Market Leadership
8.9: Marketing, Sales, and Organizational Capabilities
8.9.1: Marketing and Sales
8.9.2: Management Commitment and Track Record
8.10: Financial Strength
9. C.R Bard Inc. Profile
9.1: Company Overview
9.1.1: C.R Bard Inc. Company Description and Business Segments
9.1.2: C.R Bard Inc. Company Statistics
9.2: Structural Heart Device Business Overview
9.2.1: Structural Heart Device Business Segment
9.2.2: Global Structural Heart Device Operations
9.2.3: Key Differentiators and Strengths
9.3: Products and Product Positioning
9.3.1: Product Line Overview
9.3.2: Structural Heart Device Product Mapping
9.3.3: Product Positioning in Market Segments
9.4: Markets and Market Positioning
9.4.1: Market Position in Global Structural Heart Device Business
9.5: Revenue Breakdown by Market Segments
9.6: Revenue Breakdown by Regions
9.7: Production
9.7.1: Global Manufacturing Operations
9.8: Innovation and Market Leadership
9.9: Marketing, Sales, and Organizational Capabilities
9.9.1: Marketing and Sales
9.9.2: Management Commitment and Track Record
9.10: Financial Strength
10. CryoLife Inc. Profile
10.1: Company Overview
10.1.1: CryoLife Inc. Company Description and Business Segments
10.1.2: Cryolife Inc. Company Statistics
10.2: Structural Heart Device Business Overview
10.2.1: Structural Heart Device Business Segment
10.2.2: Global Structural Heart Device Operations
10.2.3: Key Differentiators and Strengths
10.3: Products and Product Positioning
10.3.1: Product Line Overview
10.3.2: Structural Heart Device Product Mapping
10.3.3: Product Positioning in Market Segments
10.4: Markets and Market Positioning
10.4.1: Market Position in Global Structural Heart Device Business
10.5: Revenue Breakdown by Market Segments
10.6: Revenue Breakdown by Regions
10.7: Production
10.7.1: Global Manufacturing Operations
10.8: Innovation and Market Leadership
10.9: Marketing, Sales, and Organizational Capabilities
10.9.1: Marketing and Sales
10.9.2: Management Commitment and Track Record
10.10: Financial Strength
*Full List of Figures and Tables Available on Enquiry.
1.1: Market Description
1.2: Scoring Criteria
1.3: Leadership Quadrant Analysis
1.3.1: Leaders (Top Right)
1.3.2: Contenders (Bottom Right)
1.3.3: Visionaries (Top Left)
1.3.4: Specialists (Lower Left)
2. Competitive Benchmarking
2.1: Product Portfolio Analysis
2.2: Financial Strength
2.3: Market Share Analysis
2.3.1: Market Share in Various Segments
2.3.2: Market Share in Various Regions
3. Edwards Lifesciences Corporation Profile
3.1: Company Overview
3.1.1: Edwards Lifesciences Corporation Company Description and Business Segments
3.1.2: Edwards Lifesciences Corporation Company Statistics
3.2: Structural Heart Device Business Overview
3.2.1: Structural Heart Device Business Segment
3.2.2: Global Structural Heart Device Operations
3.2.3: Key Differentiators and Strengths
3.3: Products and Product Positioning
3.3.1: Product Line Overview
3.3.2: Structural Heart Device Product Mapping
3.3.3: Product Positioning in Market Segments
3.4: Markets and Market Positioning
3.4.1: Market Position in Global Structural Heart Device Business
3.5: Revenue Breakdown by Market Segments
3.6: Revenue Breakdown by Regions
3.7: Production
3.7.1: Global Manufacturing Operations
3.8: Innovation and Market Leadership
3.9: Marketing, Sales, and Organizational Capabilities
3.9.1: Marketing and Sales
3.9.2: Management Commitment and Track Record
3.10: Financial Strength
4. Medtronic Public Limited Company Profile
4.1: Company Overview
4.1.1: Medtronic Public Limited Company Description and Business Segments
4.1.2: Medtronic Public Limited Company Statistics
4.2: Structural Heart Device Business Overview
4.2.1: Structural Heart Device Business Segment
4.2.2: Global Operations in Structural Heart Device
4.2.3: Key Differentiators and Strengths
4.3: Products and Product Positioning
4.3.1: Product Line Overview
4.3.2: Structural Heart Device Product Mapping
4.3.3: Product Positioning in Market Segments
4.4: Markets and Market Positioning
4.4.1: Market Position in Global Structural Heart Device Business
4.5: Revenue Breakdown by Market Segments
4.6: Revenue Breakdown by Regions
4.7: Production
4.7.1: Global Manufacturing Operations
4.8: Innovation and Market Leadership
4.9: Marketing, Sales, and Organizational Capabilities
4.9.1: Marketing and Sales
4.9.2: Management Commitment and Track Record
4.10: Financial Strength
5. St. Jude Medical, Inc. Profile
5.1: Company Overview
5.1.1: St. Jude Medical, Inc. Company Description and Business Segments
5.1.2: St. Jude Medical, Inc. Company Statistics
5.2: Structural Heart Device Business Overview
5.2.1: Structural Heart Device Business Segment
5.2.2: Global Structural Heart Device Operations
5.2.3: Key Differentiators and Strengths
5.3: Products and Product Positioning
5.3.1: Product Line Overview
5.3.2: Product Mapping
5.3.3: Product Positioning in Market Segments
5.4: Markets and Market Positioning
5.4.1: Market Position in Global Structural Heart Device Business
5.5: Revenue Breakdown by Market Segments
5.6: Revenue Breakdown by Regions
5.7: Production
5.7.1: Global Manufacturing Operations
5.8: Innovation and Market Leadership
5.9: Marketing, Sales, and Organizational Capabilities
5.9.1: Marketing and Sales
5.9.2: Management Commitment and Track Record
5.10: Financial Strength
6. Boston Scientific Corporation Profile
6.1: Company Overview
6.1.1: Boston Scientific Corporation Company Description and Business Segments
6.1.2: Boston Scientific Corporation Company Statistics
6.2: Structural Heart Device Business Overview
6.2.1: Structural Heart Device Business Segment
6.2.2: Global Structural Heart Device Operations
6.2.3: Key Differentiators and Strengths
6.3: Products and Product Positioning
6.3.1: Product Line Overview
6.3.2: Structural Heart Device Product Mapping
6.3.3: Product Positioning in Market Segments
6.4: Markets and Market Positioning
6.4.1: Market Position in Global Structural Heart Device Business
6.5: Revenue Breakdown by Market Segments
6.6: Revenue Breakdown by Regions
6.7: Production
6.7.1: Global Manufacturing Operations
6.8: Innovation and Market Leadership
6.9: Marketing, Sales, and Organizational Capabilities
6.9.1: Marketing and Sales
6.9.2: Management Commitment and Track Record
6.10: Financial Strength
7. LivaNova PLC Profile
7.1: Company Overview
7.1.1: LivaNova PLC Company Description and Business Segments
7.1.2: LivaNova PLC Company Statistics
7.2: Structural Heart Device Business Overview
7.2.1: Structural Heart Device Business Segment
7.2.2: Global Structural Heart Device Operations
7.2.3: Key Differentiators and Strengths
7.3: Products and Product Positioning
7.3.1: Product Line Overview
7.3.2: Structural Heart Device Product Mapping
7.3.3: Product Positioning in Market Segments
7.4: Markets and Market Positioning
7.4.1: Market Position in Global Structural Heart Device Business
7.5: Revenue Breakdown by Market Segments
7.6: Revenue Breakdown by Regions
7.7: Production
7.7.1: Global Manufacturing Operations
7.8: Innovation and Market Leadership
7.9: Marketing, Sales, and Organizational Capabilities
7.9.1: Marketing and Sales
7.9.2: Management Commitment and Track Record
7.10: Financial Strength
8. Abott Laboratories Profile
8.1: Company Overview
8.1.1: Abott Laboratories Company Description and Business Segments
8.1.2: Abott Laboratories Company Statistics
8.2: Structural Heart Device Business Overview
8.2.1: Structural Heart Device Business Segment
8.2.2: Global Structural Heart Device Operations
8.2.3: Key Differentiators and Strengths
8.3: Products and Product Positioning
8.3.1: Product Line Overview
8.3.2: Structural Heart Device Product Mapping
8.3.3: Product Positioning in Market Segments
8.4: Markets and Market Positioning
8.4.1: Market Position in Global Structural Heart Device Business
8.5: Revenue Breakdown by Market Segments
8.6: Revenue Breakdown by Regions
8.7: Production
8.7.1: Global Manufacturing Operations
8.8: Innovation and Market Leadership
8.9: Marketing, Sales, and Organizational Capabilities
8.9.1: Marketing and Sales
8.9.2: Management Commitment and Track Record
8.10: Financial Strength
9. C.R Bard Inc. Profile
9.1: Company Overview
9.1.1: C.R Bard Inc. Company Description and Business Segments
9.1.2: C.R Bard Inc. Company Statistics
9.2: Structural Heart Device Business Overview
9.2.1: Structural Heart Device Business Segment
9.2.2: Global Structural Heart Device Operations
9.2.3: Key Differentiators and Strengths
9.3: Products and Product Positioning
9.3.1: Product Line Overview
9.3.2: Structural Heart Device Product Mapping
9.3.3: Product Positioning in Market Segments
9.4: Markets and Market Positioning
9.4.1: Market Position in Global Structural Heart Device Business
9.5: Revenue Breakdown by Market Segments
9.6: Revenue Breakdown by Regions
9.7: Production
9.7.1: Global Manufacturing Operations
9.8: Innovation and Market Leadership
9.9: Marketing, Sales, and Organizational Capabilities
9.9.1: Marketing and Sales
9.9.2: Management Commitment and Track Record
9.10: Financial Strength
10. CryoLife Inc. Profile
10.1: Company Overview
10.1.1: CryoLife Inc. Company Description and Business Segments
10.1.2: Cryolife Inc. Company Statistics
10.2: Structural Heart Device Business Overview
10.2.1: Structural Heart Device Business Segment
10.2.2: Global Structural Heart Device Operations
10.2.3: Key Differentiators and Strengths
10.3: Products and Product Positioning
10.3.1: Product Line Overview
10.3.2: Structural Heart Device Product Mapping
10.3.3: Product Positioning in Market Segments
10.4: Markets and Market Positioning
10.4.1: Market Position in Global Structural Heart Device Business
10.5: Revenue Breakdown by Market Segments
10.6: Revenue Breakdown by Regions
10.7: Production
10.7.1: Global Manufacturing Operations
10.8: Innovation and Market Leadership
10.9: Marketing, Sales, and Organizational Capabilities
10.9.1: Marketing and Sales
10.9.2: Management Commitment and Track Record
10.10: Financial Strength
*Full List of Figures and Tables Available on Enquiry.
Note: Product cover images may vary from those shown
3 of 4
- Edwards Lifesciences Corporation
- Medtronic Public Limited Company
- St. Jude Medical, Inc
- Boston Scientific Corporation
- LivaNova PLC
- Abott Laboratories
- C.R Bard Inc.
- Cryolife Inc.
Note: Product cover images may vary from those shown
4 of 4
The analyst has been in the business of market research and management consulting since 2000 and has published over 600 market intelligence reports in various markets/applications and served over 1,000 clients worldwide. Each study is a culmination of four months of full-time effort performed by the analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in the market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of professionals, who have analyzed and tracked the market over the years.
Extensive research and interviews are conducted in the supply chain of the market to estimate market share, market size, trends, drivers, challenges and forecasts.
Thus, the analyst compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. The analyst then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process.
LOADING...
